Cargando…
Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347590/ https://www.ncbi.nlm.nih.gov/pubmed/30683838 http://dx.doi.org/10.1038/s41419-019-1300-3 |
| _version_ | 1783389946739949568 |
|---|---|
| author | Wei, Shuang Zhang, Zun-yi Fu, Sheng-ling Xie, Jun-gang Liu, Xian-sheng Xu, Yong-jian Zhao, Jian-ping Xiong, Wei-ning |
| author_facet | Wei, Shuang Zhang, Zun-yi Fu, Sheng-ling Xie, Jun-gang Liu, Xian-sheng Xu, Yong-jian Zhao, Jian-ping Xiong, Wei-ning |
| author_sort | Wei, Shuang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6347590 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63475902019-01-28 Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma Wei, Shuang Zhang, Zun-yi Fu, Sheng-ling Xie, Jun-gang Liu, Xian-sheng Xu, Yong-jian Zhao, Jian-ping Xiong, Wei-ning Cell Death Dis Retraction Note Nature Publishing Group UK 2019-01-25 /pmc/articles/PMC6347590/ /pubmed/30683838 http://dx.doi.org/10.1038/s41419-019-1300-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Retraction Note Wei, Shuang Zhang, Zun-yi Fu, Sheng-ling Xie, Jun-gang Liu, Xian-sheng Xu, Yong-jian Zhao, Jian-ping Xiong, Wei-ning Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma |
| title | Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma |
| title_full | Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma |
| title_fullStr | Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma |
| title_full_unstemmed | Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma |
| title_short | Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma |
| title_sort | retraction note: hsa-mir-623 suppresses tumor progression in human lung adenocarcinoma |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347590/ https://www.ncbi.nlm.nih.gov/pubmed/30683838 http://dx.doi.org/10.1038/s41419-019-1300-3 |
| work_keys_str_mv | AT weishuang retractionnotehsamir623suppressestumorprogressioninhumanlungadenocarcinoma AT zhangzunyi retractionnotehsamir623suppressestumorprogressioninhumanlungadenocarcinoma AT fushengling retractionnotehsamir623suppressestumorprogressioninhumanlungadenocarcinoma AT xiejungang retractionnotehsamir623suppressestumorprogressioninhumanlungadenocarcinoma AT liuxiansheng retractionnotehsamir623suppressestumorprogressioninhumanlungadenocarcinoma AT xuyongjian retractionnotehsamir623suppressestumorprogressioninhumanlungadenocarcinoma AT zhaojianping retractionnotehsamir623suppressestumorprogressioninhumanlungadenocarcinoma AT xiongweining retractionnotehsamir623suppressestumorprogressioninhumanlungadenocarcinoma |